CannabisNewsBreaks

ThursdayFeb 04, 2021 1:35 pm

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Continues Build Out of Highly Differentiated Business Model

Green Hygienics Holdings (OTCQB: GRYN) ("GHH") is focused on quality cultivation and processing of industrial hemp as well as manufacturing of pharmaceutical-grade bioactive cannabinoids. On the heels of its first successful crop harvest and entry into the wholesale retail stage of development, the company has engaged the services of McAllister Garfield, PC, a top law firm in the industrial hemp space. Green Hygienics made the decision in anticipation of rapid growth in 2021. “When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to be ahead of the curve and thrive,” said GRYN CEO Ron Loudoun in…

Continue Reading

ThursdayFeb 04, 2021 10:06 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a U.S.-based cannabis and hemp-branded products company, has entered into a partnership with CannRx Biosciences (“CannRx”). Based in Tel Aviv, CannRX is a leading Israeli cannabis firm focused on the development cannabis-based botanical medicine. The partnership involves using CannRx’s proprietary onset technology, CannTrap, which is a solid nano-particle, water-soluble technology that uses proteins to increase the bioavailability of cannabinoids and terpenes. CannRx works by replicating the body’s sophisticated, protein-based transport system to facilitate improved delivery of active compounds throughout the body; CannRx developed the technology for specific use with cannabinoids. The partnership calls for…

Continue Reading

WednesdayFeb 03, 2021 12:11 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) to Hold Extraordinary Meeting of Debentureholders

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, has announced an upcoming shareholder meeting. The meeting, scheduled for 10 a.m. ET on Feb. 25, 2021, is an extraordinary meeting of holders of 8% unsecured convertible debentures that are due Feb. 28, 2021. Information containing detailed information regarding the amendments and resolutions to be considered during the meeting has been mailed to the company’s debentureholders of record. The meeting will be held virtually to maintain COVID-19 social distancing requirements; participants will be attending via a telephone conference. The announcement noted that the company’s…

Continue Reading

WednesdayFeb 03, 2021 11:50 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Publication of Article Led by CEO Dr. Roger McIntyre

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by its CEO Dr. Roger McIntyre. The article, titled, “The Rapid Mood Screener (‘RMS’): a novel and pragmatic screener for bipolar I disorder,” is published at Taylor and Francis.com. "Timely and accurate diagnoses are precursors of good clinical outcomes in persons with treatment-resistant mood disorders, the high rate of missed bipolar disorder diagnosis is a critical unmet need," stated Dr. Roger McIntyre. "The Rapid Mood Screener provides a systematic approach to screening for bipolar disorder amongst all patients who present with depressive symptoms. It…

Continue Reading

WednesdayFeb 03, 2021 11:14 am

CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Signs Production Agreement with Applied Pharmaceutical Innovation

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that it has signed an agreement with Applied Pharmaceutical Innovation. A not-for-profit institution at the University of Alberta, Applied supports translational drug development for industry and innovators. XPhyto’s psychedelic pharmaceutical production agreement calls for the synthesis of pharmaceutical-grade psychedelic compounds and the development of the standard operating procedures required to obtain regulatory approval for the commercial production process. As part of its psychedelic pharmaceutical program, XPhyto needs industrial-scale production of standardized active pharmaceutical ingredients. This agreement is part of that strategic…

Continue Reading

WednesdayFeb 03, 2021 10:44 am

CannabisNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB:8OO) Announces US Symbol

HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, announced that it has secured its OTC Markets trading symbol, “CBDHF,” allowing a broader U.S. investor audience the ability to trade shares in the company. “As a U.S.-based CBD company, this important step allows a broader range of U.S. investors to access the company,” said Jason Mitchell N.D., HempFusion’s co-founder and CEO. “Additionally, we have applied for an OTCQX listing and DTC eligibility, which we expect in the coming weeks subject to the approval of the OTCQX and the satisfaction of certain…

Continue Reading

MondayFeb 01, 2021 3:44 pm

CannabisNewsBreaks – Why MAZAKALI Is ‘One to Watch’

MAZAKALI is a fintech marketplace based in San Francisco that offers investment opportunities in the high-growth cannabis industry. The company, supported by a broker/dealer and acting as a Registered Investment Adviser, has been raising capital for cannabis businesses since 2016. The company was founded to counteract negative consequences of business practices by making investments in sustainable cannabis. A recent article discussing MAZAKALI reads, “The company’s financial services leverage deep relationships, rigorous analytics and reliable research focused on uncovering investment opportunities in the high growth cannabis sector. The company features a deep bench of educated, experienced and licensed professionals to support…

Continue Reading

MondayFeb 01, 2021 3:01 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Eyes Additional Industry Opportunity, Long-Awaited Guidance

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, quickly earned a reputation as one of the fastest-growing and most innovative lifestyle brands. The company’s flagship product was a premium 8.8 pH balanced alkaline drinking water produced through an innovative, state-of-the-art proprietary electrolysis process. In 2018, WTER became publicly traded and soon expanded into the CBD space, timed perfectly with the passing of the Farm Bill, which made CBD a buzz word in the health and wellness industry. In 2020, WTER partnered with Centuria Foods and launched A88CBD(TM),…

Continue Reading

MondayFeb 01, 2021 11:46 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Will Transition Medical Business to Wholesale Model, Offer Products Through Online Platform

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has announced plans to transition its medical business to a wholesale model. In the announcement, the company noted that the strategic move aligns with other pharmaceutical products' distribution models and allows the company to reallocate resources to support growth opportunities. TGOD’s national supply agreement with Canada's largest pharmacy network, Medical Cannabis by Shoppers, means that all TGOD products will be available through an online store platform. Medical Cannabis by Shoppers is a subsidiary of Shoppers Drug Mart Inc. and is Shoppers' largest supplier of…

Continue Reading

MondayFeb 01, 2021 9:48 am

CannabisNewsBreaks – Grapefruit USA Inc.’s (GPFT) Time Release THC+CBD Delivery Cream Available on Weedmaps Retail Website

Grapefruit USA (OTCQB: GPFT), a premiere fully licensed California-based cannabis company, has announced that its patented Hourglass(TM) time-release THC+cannabinoid delivery cream is now available in California through Weedmaps’ retail online platform. GPFT’s disruptive Hourglass product features a patented technology that overcomes the challenge of efficient skin absorption of THC and other cannabinoids. The topical cannabis delivery cream enables users to see positive results of a predictable delivery of THC/cannabinoids over time. "The approval of Grapefruit on the Weedmaps' cannabis product platform represents a milestone for our company because it affirms Hourglass' efficacy and makes it simple for our clientele to…

Continue Reading